Olaparib First-Line Maintenance Monotherapy in BRCA-Mutated Epithelial Ovarian Cancer: Descriptive Analysis of the First French Real-World Data Study-Reference-Cited by-同舟云学术

Olaparib First-Line Maintenance Monotherapy in BRCA-Mutated Epithelial Ovarian Cancer: Descriptive Analysis of the First French Real-World Data Study

Published:2023-01-11 Issue:2 Volume:10 Page:207-213
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Bellier Charlotte,Gladieff Laurence,Le Du Fanny,Berton Dominique,Bonnard Charlotte,Suau Delphine,Richard Anne-Céline,Brenner Ophélie,Lahouegue Amir,Freyer Gilles,Floquet Anne,Frank Sophie,Kfoury Maria

Funder

AstraZeneca

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40801-022-00349-9.pdf

Reference23 articles.

1. Institut National du Cancer. Recommandations professionnelles: cancer de l’ovaire. Traitement chirurgical. Juin 2019. Available from: www.e-cancer.fr. [Accessed 19 Dec 2022].

2. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5: a population-based study. Lancet Oncol. 2014;15(1):23–34. https://doi.org/10.1016/S1470-2045(13)70546-1.

3. Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(6):24–32. https://doi.org/10.1093/annonc/mdt333.

4. Lambert HE, Rustin GJ, Gregory WM, Nelstrop AE. A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma: a North Thames Ovary Group study. Ann Oncol. 1997;8(4):327–33.

5. Bookman MA, Brady MF, McGuire WP, Harper PG, Alberts DS, Friedlander M, et al. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a phase III trial of the Gynecologic Cancer Intergroup. J Clin Oncol. 2009;27(9):1419–25.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new wave of innovations within the DNA damage response;Signal Transduction and Targeted Therapy;2023-09-08